Important: This guide is educational. It does not recommend kratom, provide dosing advice, or promise any medical, mood, energy, pain, withdrawal, or other physiological effect. Color and variety names are not guarantees of safety, potency, composition, legality, or suitability for an individual. Review the actual product form, ingredients, lot information, laboratory report, warnings, and current destination restrictions.
The short answer
Green, Red and White are useful catalog families, but they are not nationally standardized grades. Maeng Da, Bali, Hulu, Ketapang, Vietnam and Malay are familiar commercial variety names, but the name alone does not prove a specific farm, country, cultivar, alkaloid profile, potency, or effect.
All of Kiody’s ordinary pure-leaf products should be identified first by what they actually are: botanical leaf material from the species Mitragyna speciosa. Kew Science recognizes Mitragyna speciosa Korth. as an accepted species in the coffee family, Rubiaceae, native from southern Indo-China to New Guinea. Kew Plants of the World Online
The catalog name comes after that identity. A responsible product page should let customers distinguish among:
- the species;
- the product form, such as leaf powder or pure-leaf capsules;
- the commercial color family;
- the commercial variety name;
- the specific lot or batch;
- the measured information on that lot’s laboratory report; and
- the package quantity and options being purchased.
That order prevents a colorful name from carrying more meaning than the evidence supports.
“Strain” is common shopping language, not a complete specification
Many online stores call every color-and-name combination a strain. Customers understand phrases such as Green Maeng Da or Red Bali, so removing the word entirely may make a catalog harder to navigate. But using the term responsibly requires context.
In a plant-science setting, a cultivar, accession, genotype, chemotype, population, and commercial blend are different things. A retail strain name does not establish any one of those categories by itself. Unless Kiody has documented genetics, controlled cultivation records, verified geographic origin, and a defined product specification, the safer description is commercial variety name or catalog variety.
That does not make the name meaningless. It can identify the supplier specification, processing stream, sensory characteristics, internal formulation, and inventory line that Kiody intends to keep consistent. It simply means that the customer should not treat the name as a scientific certificate.
The University of Florida College of Pharmacy notes that red, white and green distinctions are advertised for different effects in Western markets, that the distinction was not made the same way in traditional-use settings, and that the leaves come from the same species. Its consumer resource cautions that evidence establishing different effects from these vein-color categories is limited. University of Florida Kratom Resources
What the color family can—and cannot—tell you
What it can tell you
On a well-managed Kiody catalog, Green, Red and White can tell a customer which commercial product family they are viewing. The color should be consistent across the product title, package art, variation selector, category, breadcrumb, image alt text, SKU convention, invoice, and fulfillment label.
That consistency is valuable. A customer who orders White Vietnam should not receive a pouch labeled Green Vietnam, and a Red Bali lot report should not be attached to a Green Bali page. Color is therefore an important identity and fulfillment field, even when it is not a universal chemical standard.
What it cannot tell you
Color alone cannot verify:
- the country or farm of origin;
- a unique genetic line;
- the harvest date or season;
- the leaf age;
- the drying or postharvest method;
- the absence of blending;
- the concentration of a particular alkaloid;
- the microbiological or heavy-metal result;
- whether the product is ordinary leaf, extract, enhanced material, or a mixture;
- a predictable effect for every person; or
- whether the product is permitted at a particular destination.
Those facts require separate records and testing.
What current research says about color labels
Research supports a more careful explanation than the standard internet chart claiming that every Red product does one thing, every White product does another, and every Green product sits in the middle.
A 2023 study examined commercial products labeled red, green and white. The researchers analyzed measured alkaloids and surveyed 644 current users. Participants reported different experiences and reasons for choosing the marketed categories, but the chemical analysis did not find significant differences in the targeted alkaloids across the commercial strain designations. The study is useful evidence that customer expectations and reported experiences can exist even when a label does not reliably predict the measured profile. It does not prove that every product bearing the same color is identical. Huisman et al., 2023
A 2026 plant-science study reviewing prior commercial findings likewise notes that products marketed as green, red and white did not show significant differences in total or individual measured monoterpene indole alkaloids across those designations. The same paper also reports that samples from controlled Thai collections varied with genetics and season, while prior work found no significant targeted-alkaloid differences between vein colors within the seasonal collection. Ransden et al., 2026
Another recent study found that genotype, season and postharvest handling can materially influence alkaloid composition and concentration. That matters for product literacy: even genuine plant variation may not line up neatly with a retail name printed on the front of a pouch. Zhang et al., 2025
The responsible conclusion is not that all kratom products are identical. It is that the commercial name is not enough evidence to predict a batch. Supplier controls, processing records, lot identity and batch-specific analysis are stronger tools than a universal strain-effects chart.
Why a powder’s visible color is not a chemical certificate
Customers may reasonably expect a Green product to look greener than a Red product, but powder appearance can change for many reasons. Particle size, lighting, camera settings, moisture, storage, oxidation, drying, leaf age, blending, and normal agricultural variation can affect appearance.
A responsible seller should use accurate product photography of the fulfilled package and, when practical, the actual powder. It should not digitally recolor powder to force it into a category. A warm olive powder is not automatically mislabeled, and a bright green powder is not automatically stronger, fresher, cleaner, or safer.
Visual inspection can identify obvious problems such as unexpected debris, damaged packaging, moisture intrusion, or a major mismatch. It cannot replace identity testing, contaminant testing, or the lot-linked certificate of analysis.
Understanding the six Kiody variety names
The following descriptions are designed for honest catalog navigation. They deliberately avoid assigning medical or guaranteed-effect profiles.
Maeng Da
Maeng Da is one of the most recognized names in the U.S. kratom market. On Kiody, it should mean the specific Maeng Da product line supplied, documented, packaged, and tracked under Kiody’s system. It should not be described as automatically more potent, genetically superior, or clinically different from every non-Maeng Da product unless the exact claim is supported by appropriate evidence.
Recommended product-page wording: “Maeng Da is the commercial variety name for this Kiody pure-leaf product. Because commercial names are not universal chemical standards, review the exact lot information and matching laboratory report rather than relying on the name as a potency or effect guarantee.”
Bali
Bali is a familiar commercial name and also a geographic name. A product called Bali does not, by itself, establish that the leaf was grown, harvested, milled, or exported from Bali. If A responsible seller can document origin for a lot, the page may state the verified origin precisely. If not, Bali should be presented as the product’s commercial variety name.
Recommended product-page wording: “Bali identifies this Kiody catalog variety. It is not, by itself, a verified geographic-origin claim. See the package and lot documentation for the facts confirmed for the current batch.”
Hulu
Hulu is widely used in commercial catalogs, often in longer forms such as Hulu Kapuas. A responsible seller should use only the name supported by its supplier and product records. The page should not add a river, region, harvest story, or traditional-use narrative unless those facts are documented for the lot or sourcing program.
Recommended product-page wording: “Hulu is Kiody’s commercial variety name for this pure-leaf product. The listing identifies the actual form, quantity, package options, and batch documentation separately.”
Ketapang
Ketapang is both a place name in Indonesia and a commercial kratom variety name. The label should not be treated as proof of county, regency, farm, or forest origin without traceability records. A responsible seller can still maintain Ketapang as a distinct inventory and customer-selection line.
Recommended product-page wording: “Ketapang identifies this catalog variety; it does not independently certify geographic origin or a standardized alkaloid profile. Use the current lot report for measured batch information.”
Vietnam
Vietnam is a country name, but a Vietnam-labeled retail product is not automatically a country-of-origin certification. The actual origin should appear only when Kiody has records that support the claim and when the wording is consistent with customs, supplier, packaging, and traceability documentation.
Recommended product-page wording: “Vietnam is the commercial variety name used for this Kiody product. Any verified country-of-origin information is stated separately in the lot or sourcing documentation.”
Malay
Malay is commonly used as a commercial variety name and can suggest Malaysia or the broader Malay world. A responsible seller should not convert that association into an undocumented farm or country claim. Research has found geographic and genetic variation among Mitragyna speciosa accessions, which is exactly why a broad name should not substitute for current lot evidence.
Recommended product-page wording: “Malay identifies the catalog variety. It is not a universal cultivar, potency level, or effect specification. Review the current batch information before comparing it with another seller’s Malay-labeled product.”
A practical way to compare Kiody’s 18 core combinations
Kiody’s core matrix contains three color families and six commercial variety names:
| Color family | Maeng Da | Bali | Hulu | Ketapang | Vietnam | Malay |
|---|---|---|---|---|---|---|
| Green | Green Maeng Da | Green Bali | Green Hulu | Green Ketapang | Green Vietnam | Green Malay |
| Red | Red Maeng Da | Red Bali | Red Hulu | Red Ketapang | Red Vietnam | Red Malay |
| White | White Maeng Da | White Bali | White Hulu | White Ketapang | White Vietnam | White Malay |
Powder and capsules: same variety, different product form
If a Kiody capsule contains the same pure leaf powder as the corresponding powder SKU, the product pages should say so plainly after operational verification. The capsule shell and fill information must also be disclosed accurately.
“Approximately 500 mg per capsule” describes nominal leaf-powder fill. It does not mean 500 mg of mitragynine, 7-OH, or total alkaloids. It is not a dose recommendation and does not make capsules chemically standardized.
Powder and capsules should have distinct SKUs, images, quantity selectors, structured data, and fulfillment checks. Customers should never have to guess whether a product title refers to loose powder or capsules.
Why the lot matters more than the legend
Agricultural products can vary. Research points to genotype, season, geography, postharvest handling, and mixing as possible contributors to compositional differences. That makes the lot number the bridge between a general product page and the specific material inside a package.
A useful lot system allows Kiody to connect:
supplier or source record → received material → internal lot → test report → packaging run → finished SKU → customer order → complaint or recall record
The matching certificate of analysis should identify the sample, laboratory, methods or analytes, results, units, and dates clearly enough for a reviewer to understand what was tested. A COA does not establish every possible quality or safety fact, but it is more informative than assuming that all Red Bali or all Green Maeng Da products share a universal profile.
Keep ordinary leaf separate from extracts and enhanced 7-OH
Color and variety names should never obscure product form. A pouch of ordinary botanical leaf powder, a pure-leaf capsule, a concentrated extract, and a product with added or enhanced 7-hydroxymitragynine are not interchangeable.
FDA communications distinguish trace naturally occurring 7-OH associated with leaf from concentrated products containing added or enhanced levels. The agency has specifically warned about products such as 7-OH tablets, gummies, drink mixes, and shots. FDA 7-OH warning-letter announcement
Kiody product titles, categories, images, ingredients, warnings, COAs, and structured data should make the form immediately clear. An enhanced product should never borrow a familiar leaf-strain name in a way that could cause a customer to mistake it for ordinary powder.
Effect charts create more risk than clarity
A chart that assigns “energy” to every White product, “balance” to every Green product, and “relaxation” or “pain relief” to every Red product is easy to scan, but it overstates what the color label establishes.
FDA and FTC enforcement has addressed websites that attached disease, withdrawal, blood-pressure, depression, and other treatment claims to named kratom products. In a 2022 joint FDA/FTC warning letter, product names included Red Maeng Da, Super Green, and White Maeng Da; the problem was not the existence of color categories, but the unsupported drug and health claims attached to them. FDA/FTC warning letter
A responsible seller can write informative, search-friendly pages without promising an experience. Useful subjects include identity, format, quantity, traceability, testing literacy, packaging, storage, current restrictions, and the difference between a catalog name and a scientific specification.
Frequently asked questions
Are Green, Red and White separate kratom species?
No. Ordinary products in these catalog families are generally presented as material from Mitragyna speciosa. The color label is not a separate species name.
Is one color proven stronger than another?
No universal rule makes one commercial color category stronger. The label alone does not establish a measured alkaloid concentration or predictable effect.
Does Red Bali have to come from Bali?
Not based on the name alone. A geographic-origin claim requires sourcing and traceability evidence. Without that evidence, Bali should be treated as a commercial variety name.
Is Maeng Da a standardized cultivar?
Not across the U.S. retail market. Sellers may use the name for different supplier specifications, blends, or product lines. Compare the actual product form and lot documentation.
Do commercial colors have different alkaloids?
Mitragyna speciosa can show compositional variation, but research has not established a simple, universal color rule for commercial products. Genetics, season, geography, processing, mixing, and batch variation can matter.
Why do two products with the same name look different?
Agricultural variation, particle size, lighting, storage, moisture, drying, oxidation, processing, or blending may change appearance. A visible difference should prompt a package and lot check; appearance alone cannot determine composition or safety.
Are Green Bali powder and Green Bali capsules identical?
They are different finished product forms. They may use the same leaf powder only if Kiody’s batch and manufacturing records confirm it. Capsules also include a shell and have a stated nominal fill.
Does 500 mg per capsule mean 500 mg of active alkaloids?
No. When verified, it means approximately 500 mg of leaf powder per capsule. It is not the amount of mitragynine, 7-OH, or total alkaloids and is not dosing advice.
Can I use the color name to choose a medical result?
No. A responsible seller should not use color or variety names as treatment recommendations. Discuss health questions with a qualified healthcare professional.
Is a color-and-variety name enough to compare two brands?
No. Compare ingredients, form, quantity, lot identity, current testing, packaging, warnings, support, and verified sourcing claims. Two sellers can use the same commercial name for materially different products.
Where should I find the most reliable product information?
Start with the actual package and lot number, then match them to the correct Kiody listing and laboratory report. Contact Kiody if the information conflicts or the report is missing.
Primary and authoritative sources
- Royal Botanic Gardens, Kew, Plants of the World Online, Mitragyna speciosa Korth.: https://powo.science.kew.org/taxon/urn%3Alsid%3Aipni.org%3Anames%3A756303-1/general-information
- University of Florida College of Pharmacy, Kratom Resources: https://csp.pharmacy.ufl.edu/research/kratom/
- Huisman et al., “Examining the Psychoactive Differences between Kratom Strains,” 2023: https://pmc.ncbi.nlm.nih.gov/articles/PMC10379209/
- Ransden et al., “Comparative analysis of monoterpene indole alkaloid composition and genotypic variation in Thai Mitragyna speciosa,” 2026: https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2026.1821609/full
- Zhang et al., “Alkaloid biosynthesis in medicinal crop kratom,” 2025: https://pmc.ncbi.nlm.nih.gov/articles/PMC12516786/
- FDA, “FDA and Kratom,” updated December 2, 2025: https://www.fda.gov/news-events/public-health-focus/fda-and-kratom
- FDA, 7-OH warning-letter announcement, July 15, 2025: https://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-firms-marketing-products-containing-7-hydroxymitragynine
- FDA and FTC, Kratom Exchange Warning Letter, June 30, 2022: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kratom-exchange-633972-06302022
- Google Search Central, “Creating Helpful, Reliable, People-First Content”: https://developers.google.com/search/docs/fundamentals/creating-helpful-content